Vanguard Group Inc. Filing Update for GoodRx Holdings Inc.

Vanguard Group Inc. has filed an amendment (8) to its Schedule 13G, reporting on its holdings of GoodRx Holdings Inc. common stock as of March 13, 2026. The filing indicates that Vanguard Group, acting as an investment adviser, has the power to direct dividends and sale proceeds for the reported securities. While the filing states that no single person has more than a 5% interest, Vanguard Group, Inc. has undergone an internal realignment effective January 12, 2026. Consequently, certain subsidiaries now report beneficial ownership separately. The filing asserts that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing the control of the issuer. As of the filing date, the reported beneficial ownership and voting power are listed as 0, with a previous value of 25,973,136.0 and previous shares of 9,584,183.0.